SHIME®: an advanced in vitro technology platform for studying the mode-of-action of probiotics in the gastrointestinal tract
The gastrointestinal microbiota plays a key role in human health. Over the past few decades, a lot of attention has been directed at improving health by modulating the gut microbial composition using probiotics. In vivo studies have limitations in providing mechanistic insights into the effect of probiotics and cannot be used to screen numerous test compounds. However, in vitro approaches can be used for mechanistic research under highly controlled environmental conditions. Here we describe how the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) can be used to produce data complementary to in vivo studies to help elucidate the mode-of-action of probiotics in the gastrointestinal tract.
DOI: 10.17470/NF-018-1023-4
DATE: 2018
AUTHOR/S: Duysburgh C, Van den Abbeele P, Marzorati M
ABSTRACT:
The gastrointestinal microbiota plays a key role in human health. Over the past few decades, a lot of attention has been directed at improving health by modulating the gut microbial composition using probiotics. In vivo studies have limitations in providing mechanistic insights into the effect of probiotics and cannot be used to screen numerous test compounds. However, in vitro approaches can be used for mechanistic research under highly controlled environmental conditions. Here we describe how the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) can be used to produce data complementary to in vivo studies to help elucidate the mode-of-action of probiotics in the gastrointestinal tract.
KEYWORDS:
SHIME®, Intestine, Microbiota, Health, Anti-pathogenic activity
10.17470/NF-018-1023-4